Brain region‐dependent differential expression of alpha‐synuclein

α‐Synuclein, the major constituent of Lewy bodies (LBs), is normally expressed in presynapses and is involved in synaptic function. Abnormal intracellular aggregation of α‐synuclein is observed as LBs and Lewy neurites in neurodegenerative disorders, such as Parkinson's disease (PD) or dementia with Lewy bodies. Accumulated evidence suggests that abundant intracellular expression of α‐synuclein is one of the risk factors for pathological aggregation. Recently, we reported differential expression patterns of α‐synuclein between excitatory and inhibitory hippocampal neurons. Here we further investigated the precise expression profile in the adult mouse brain with special reference to vulnerable regions along the progression of idiopathic PD. The results show that α‐synuclein was highly expressed in the neuronal cell bodies of some early PD‐affected brain regions, such as the olfactory bulb, dorsal motor nucleus of the vagus, and substantia nigra pars compacta. Synaptic expression of α‐synuclein was mostly accompanied by expression of vesicular glutamate transporter‐1, an excitatory presynaptic marker. In contrast, expression of α‐synuclein in the GABAergic inhibitory synapses was different among brain regions. α‐Synuclein was clearly expressed in inhibitory synapses in the external plexiform layer of the olfactory bulb, globus pallidus, and substantia nigra pars reticulata, but not in the cerebral cortex, subthalamic nucleus, or thalamus. These results suggest that some neurons in early PD‐affected human brain regions express high levels of perikaryal α‐synuclein, as happens in the mouse brain. Additionally, synaptic profiles expressing α‐synuclein are different in various brain regions. J. Comp. Neurol. 524:1236–1258, 2016. © 2015 Wiley Periodicals, Inc.

[1]  M. Martina,et al.  α-Synuclein Expression in the Mouse Cerebellum Is Restricted to VGluT1 Excitatory Terminals and Is Enriched in Unipolar Brush Cells , 2015, The Cerebellum.

[2]  R. D'Hooge,et al.  Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors , 2015, Neurobiology of Aging.

[3]  F. Fujiyama,et al.  Singular localization of sodium channel β4 subunit in unmyelinated fibres and its role in the striatum , 2014, Nature Communications.

[4]  Manuela Pendziwiat,et al.  Differential aggregation properties of alpha-synuclein isoforms , 2014, Neurobiology of Aging.

[5]  P. Calabresi,et al.  Direct and indirect pathways of basal ganglia: a critical reappraisal , 2014, Nature Neuroscience.

[6]  Masaki Tanaka,et al.  Differential Expression of Alpha-Synuclein in Hippocampal Neurons , 2014, PloS one.

[7]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[8]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[9]  L. Stefanis α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[10]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[11]  M. Luquin,et al.  Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders , 2011, Acta Neuropathologica.

[12]  F. Fornai,et al.  Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies , 2011, Journal of Chemical Neuroanatomy.

[13]  Paul T. Schumacker,et al.  Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.

[14]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[15]  Zayd M. Khaliq,et al.  Pacemaking in Dopaminergic Ventral Tegmental Area Neurons: Depolarizing Drive from Background and Voltage-Dependent Sodium Conductances , 2010, The Journal of Neuroscience.

[16]  M. A. Basso,et al.  The basal ganglia: An overview of circuits and function , 2008, Neuroscience & Biobehavioral Reviews.

[17]  H. Uylings,et al.  Gender‐related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients , 2008, Movement disorders : official journal of the Movement Disorder Society.

[18]  H. Braak,et al.  Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered , 2008, Experimental Neurology.

[19]  Vadim Zinchuk,et al.  Quantitative Colocalization Analysis of Confocal Fluorescence Microscopy Images , 2008, Current protocols in cell biology.

[20]  V. Zinchuk,et al.  Quantitative Colocalization Analysis of Confocal Fluorescence Microscopy Images , 2008, Current protocols in cell biology.

[21]  Hitoshi Takahashi,et al.  α-Synuclein pathology in the neostriatum in Parkinson’s disease , 2008, Acta Neuropathologica.

[22]  I. Ferrer,et al.  Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases , 2008, Neurogenetics.

[23]  Z. J. Huang,et al.  Development of GABA innervation in the cerebral and cerebellar cortices , 2007, Nature Reviews Neuroscience.

[24]  T. Kosaka,et al.  Neuronal gap junctions in the mouse main olfactory bulb: Morphological analyses on transgenic mice , 2005, Neuroscience.

[25]  S. Totterdell,et al.  Localization of Alpha-synuclein to identified fibers and synapses in the normal mouse brain , 2005, Neuroscience.

[26]  G. Miller,et al.  Reduced MPTP toxicity in noradrenaline transporter knockout mice , 2004, Journal of neurochemistry.

[27]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[28]  B. Fyk-Kolodziej,et al.  Immunocytochemical localization of three vesicular glutamate transporters in the cat retina , 2004, The Journal of comparative neurology.

[29]  S. Totterdell,et al.  The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain , 2004, Brain Research.

[30]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[31]  H. Braak,et al.  Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.

[32]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[33]  J. Payton,et al.  Epitope mapping and specificity of the anti-α-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines , 2003, Neuroscience Letters.

[34]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.

[35]  F. Fujiyama,et al.  Differential distribution of vesicular glutamate transporters in the rat cerebellar cortex , 2003, Neuroscience.

[36]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[37]  A. Dahlström,et al.  Differential localization of α-, β- and γ-synucleins in the rat CNS , 2002, Neuroscience.

[38]  Hitoshi Takahashi,et al.  Immunohistochemical comparison of α- and β-synuclein in adult rat central nervous system , 2002, Brain Research.

[39]  Udo Rüb,et al.  Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.

[40]  D. Dickson,et al.  Alpha-synuclein and the Lewy body disorders. , 2001, Current opinion in neurology.

[41]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[42]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[43]  J. Mikkelsen,et al.  Developmental expression of α-synuclein in rat hippocampus and cerebral cortex , 1999, Neuroscience.

[44]  L. Thal,et al.  Expression Pattern of Synucleins (Non‐Aβ Component of Alzheimer's Disease Amyloid Precursor Protein/α‐Synuclein) During Murine Brain Development , 1998 .

[45]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[46]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[47]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[48]  G. Withers,et al.  Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. , 1997, Brain research. Developmental brain research.

[49]  J. Kimura,et al.  Large neurons in the tuberomammillary nucleus in patients with Parkinson's disease and multiple system atrophy , 1996, Neurology.

[50]  R. J. Mullen,et al.  NeuN, a neuronal specific nuclear protein in vertebrates. , 1992, Development.

[51]  P. M. Groves,et al.  A GABA immunocytochemical study of rat motor thalamus: Light and electron microscopic observations , 1991, Neuroscience.

[52]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[53]  L. Reichardt,et al.  Identification of a synaptic vesicle-specific membrane protein with a wide distribution in neuronal and neurosecretory tissue , 1981, The Journal of cell biology.

[54]  Samir Guglani Death , 1890, The Lancet.

[55]  J. Dorszewska,et al.  [Alpha-synuclein in Parkinson's disease]. , 2014, Przeglad lekarski.

[56]  A. Kakita,et al.  alpha-Synuclein pathology in the neostriatum in Parkinson's disease. , 2008, Acta neuropathologica.

[57]  J. McGinty Co-localization of GABA with other neuroactive substances in the basal ganglia. , 2007, Progress in brain research.

[58]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[59]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[60]  Hitoshi Takahashi,et al.  Immunohistochemical comparison of alpha- and beta-synuclein in adult rat central nervous system. , 2002, Brain research.

[61]  A. Dahlström,et al.  Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS. , 2002, Neuroscience.

[62]  B. Hyman,et al.  Cortical neurons expressing calcium binding proteins are spared in dementia with Lewy bodies , 2000, Acta Neuropathologica.

[63]  D. Sulzer,et al.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. , 2000, Neuron.

[64]  J. Mikkelsen,et al.  Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex. , 1999, Neuroscience.

[65]  R A Crowther,et al.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  L. Thal,et al.  Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development. , 1998, Journal of neurochemistry.

[67]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[68]  Charles J. Wilson,et al.  The generation of natural firing patterns in neostriatal neurons. , 1993, Progress in brain research.